The role of the phosphatase and tensin homolog status in predicting pathological complete response to neoadjuvant anti-HER2 therapies in HER2-positive primary breast cancer: A meta-analysis.

Zhang, Chi; Guo, Ying; Li, Jiyu; Tian, Xingsong; Duan, Xuening

Zhang, Chi; Guo, Ying; Li, Jiyu; Tian, Xingsong; Duan, Xuening.

Afiliación

Zhang C; Department of Breast and Thyroid Surgery, Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong Province.
Guo Y; Department of Breast and Thyroid Surgery, Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong Province.
Li J; Department of Breast and Thyroid Surgery, Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong Province.
Tian X; Department of Breast and Thyroid Surgery, Shandong Provincial Hospital affiliated to Shandong University, Jinan, Shandong Province.
Duan X; Breast Disease Centre, Peking University First Hospital, Beijing, China.

Medicine (Baltimore) ; 98(5): e14261, 2019 Feb.

Article en En | MEDLINE | ID: mdl-30702584

Asunto(s)

Neoplasias de la Mama/tratamiento farmacológico; Terapia Neoadyuvante/métodos; Fosfohidrolasa PTEN/sangre; Receptor ErbB-2/biosíntesis; Biomarcadores de Tumor; Neoplasias de la Mama/terapia; Femenino; Humanos; Fosfohidrolasa PTEN/biosíntesis; Trastuzumab/uso terapéutico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Terapia Neoadyuvante / Fosfohidrolasa PTEN Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Medicine (Baltimore) Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google